Robert Michael

Chairman and CEO, AbbVie

North Chicago, Illinois

About

Robert A. Michael is the Chairman of the Board and Chief Executive Officer of AbbVie, a biopharmaceutical company with products in immunology, neuroscience, oncology and aesthetics. He became CEO in July 2024, after serving as President and Chief Operating Officer, and the board added the chairman role in July 2025.

Michael first joined Abbott in 1993. He joined AbbVie in 2013. At AbbVie he was Chief Financial Officer from 2018, Vice Chairman and President from 2022, and President and Chief Operating Officer from 2023, before becoming CEO. Other pharmaceutical company chief executives on Whoo include David Ricks of Eli Lilly and Robert Bradway of Amgen.

Whoo compiled this page from public sources: AbbVie 2026 proxy statement (SEC), AbbVie press release, July 2024 (PR Newswire), Medical Dialogues, February 2025, AbbVie 2025 annual report (SEC). It is not affiliated with or endorsed by Robert Michael. Are you Robert Michael? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.

Want a page like this? Create yours from your résumé.

Experience

Chairman and Chief Executive Officer — AbbVie


2024 – Present

  • Became CEO in July 2024 and chairman in July 2025
  • President and Chief Operating Officer — AbbVie


    2023 – 2024

  • Oversaw commercial operations, finance, human resources, operations, business development and strategy
  • Vice Chairman and President — AbbVie


    2022 – 2023

    Vice Chairman, Finance and Commercial Operations, and Chief Financial Officer — AbbVie


    2021 – 2022

    Executive Vice President and Chief Financial Officer — AbbVie


    2019 – 2021

    Senior Vice President and Chief Financial Officer — AbbVie


    2018 – 2019

    Leadership roles in several business units — Abbott


    1993 – 2013

  • Held leadership roles across several business units before moving to AbbVie in 2013

Education

Education


Not published in sources

Projects